Cargando…
Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer
SIMPLE SUMMARY: In this study, we generate an innovative endogenous progesterone receptor (PR) reporter gene containing endometrial cancer cell lines and use this tool to visualize PR expression in real-time. We also demonstrated two strategies of using this reporter gene: (1). Drug discovery—screen...
Autores principales: | Li, Yiyang, Zhou, Wei, Meng, Xiangbing, Murray, Sarina D., Li, Long, Fronk, Abby, Lazaro-Camp, Vanessa J., Wen, Kuo-kuang, Wu, Meng, Dupuy, Adam, Leslie, Kimberly K., Yang, Shujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561963/ https://www.ncbi.nlm.nih.gov/pubmed/36230806 http://dx.doi.org/10.3390/cancers14194883 |
Ejemplares similares
-
Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer
por: Kavlashvili, Tamar, et al.
Publicado: (2016) -
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer
por: Yang, Shujie, et al.
Publicado: (2014) -
The Interplay Between the DNA Damage Response, RNA Processing and Extracellular Vesicles
por: Meng, Xiangbing, et al.
Publicado: (2020) -
Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53
por: Meng, Xiangbing, et al.
Publicado: (2013) -
Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment
por: Meng, Xiangbing, et al.
Publicado: (2011)